Fennec Pharmaceuticals Inc. (FRA:RV41)
6.45
-0.15 (-2.27%)
Last updated: Dec 16, 2025, 8:05 AM CET
Fennec Pharmaceuticals Employees
Fennec Pharmaceuticals had 32 employees as of December 31, 2024. The number of employees increased by 3 or 10.34% compared to the previous year.
Employees
32
Change (1Y)
3
Growth (1Y)
10.34%
Revenue / Employee
€1,033,147
Profits / Employee
€184,816
Market Cap
223.26M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 32 | 3 | 10.34% |
| Dec 31, 2023 | 29 | -7 | -19.44% |
| Dec 31, 2022 | 36 | 26 | 260.00% |
| Dec 31, 2021 | 10 | 1 | 11.11% |
| Dec 31, 2020 | 9 | 5 | 125.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Deutsche Post AG | 573,964 |
| Siemens Aktiengesellschaft | 317,562 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,995 |
Fennec Pharmaceuticals News
- 12 days ago - Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell Tumors - GlobeNewsWire
- 19 days ago - Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK in Japan to Reduce Cisplatin-Induced Hearing Loss - Wallstreet:Online
- 19 days ago - Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss - GlobeNewsWire
- 25 days ago - Fennec Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Fennec Pharmaceuticals (FENC) Eliminates Debt with Convertible Notes Buyback - GuruFocus
- 4 weeks ago - Fennec Pharmaceuticals Announces Closing of Offering of Common Shares - GlobeNewsWire
- 5 weeks ago - Fennec Pharmaceuticals (FENC) Plans $5.025M Share Offering in Canada - GuruFocus
- 5 weeks ago - Fennec Pharmaceuticals plans share offering in Canada to raise up to $5 million - Seeking Alpha